RESUMO
BACKGROUND: Implanted peroneal functional electrical stimulation (FES) is an effective alternative treatment to ankle-foot orthosis (AFO) in people with drop foot after stroke. With FES no constraints on ankle mobility are imposed which might particularly be exploited in challenging walking environments that require adaptations of the gait pattern to environmental disturbances. RESEARCH QUESTION: Is gait adaptability, by means of the capacity to avoid sudden obstacles while walking on a treadmill, superior with implanted FES compared to AFO in people with drop foot after stroke? METHODS: A 4-channel peroneal nerve stimulator (ActiGait®) was implanted in 22 persons with stroke (>6 months) who regularly used an AFO. Gait adaptability was tested with an obstacle avoidance task on an instrumented treadmill up to 26 weeks (n = 10) or 52 weeks (n = 12) after FES-system activation. At assessments, 30 trials, in which obstacles were suddenly dropped onto the treadmill in front of the paretic leg, were recorded with each device (FES / AFO). Trials were grouped by available response times (ART) and success rates were calculated. The effect of device, ART and follow up time on success rates was tested using generalized estimated equations. Nonparametric correlations were calculated to associate changes in success rates with clinimetrics. RESULTS: Success rates of obstacle avoidance were higher when participants used their FES system compared to AFO (Δ4.7%, p = 0.03), which effect was largest for longest ARTs (Δ15%, p = 0.03). Participants with greater motor impairment of the paretic leg showed greater benefit from FES (rs=-0.49, p = 0.04). SIGNIFICANCE: FES has been found equally effective as AFO in improving walking speed of people with drop foot after stroke. We now present superior walking performance in a complex walking environment for implanted peroneal FES compared to AFO. These findings underline the importance of using gait assessments that require interplay with the environment, besides assessment of stationary walking, in community ambulators.
Assuntos
Terapia por Estimulação Elétrica , Marcha , Aparelhos Ortopédicos , Neuropatias Fibulares/terapia , Acidente Vascular Cerebral , Adaptação Fisiológica , Teste de Esforço , Feminino , Humanos , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Países Baixos , Neuropatias Fibulares/reabilitação , Reabilitação do Acidente Vascular Cerebral , Resultado do TratamentoRESUMO
PURPOSE: To investigate whether an implantable functional electrical stimulation (FES) system of the common peroneal nerve (ActiGait®) improves relevant aspects of gait in chronic stroke patients with a drop foot typically using an ankle-foot orthosis (AFO). METHODS: Ten community-dwelling patients participated, of whom eight patients could be analysed. Gait quality (kinematic, kinetic, and spatiotemporal characteristics) during a 10-meter comfortable walk test, normalised net energy expenditure during a 6-minute walk test, participation (physical activity and stroke impact) and user satisfaction were tested before implantation and at various moments after FES-system activation up to 26 weeks. RESULTS: Walking with FES yielded increased maximum paretic ankle plantarflexion (FES: -0.12; AFO: -4.79°, pâ< â0.01), higher paretic peak ankle power (FES: 1.46; AFO: 0.98âW/kg, pâ< â0.05) and better step length symmetry (FES: 14.90; AFO: 21.45% , pâ< â0.05). User satisfaction was higher for FES, but was unrelated to objective gait improvements. Energy expenditure and participation did not change. CONCLUSION: Implantable FES improved the use of residual ankle plantarflexion motion, ankle power of the paretic leg and step length symmetry compared to using an AFO, however, not resulting in decreased energy expenditure or improved participation. User satisfaction was highest with FES, but this was not related to the observed gait improvements.
Assuntos
Terapia por Estimulação Elétrica/métodos , Órtoses do Pé , Marcha/fisiologia , Nervo Fibular/fisiopatologia , Reabilitação do Acidente Vascular Cerebral , Acidente Vascular Cerebral/fisiopatologia , Tornozelo/fisiopatologia , Fenômenos Biomecânicos , Terapia por Estimulação Elétrica/instrumentação , Terapia por Estimulação Elétrica/psicologia , Metabolismo Energético , Feminino , Pé/fisiologia , Humanos , Neuroestimuladores Implantáveis , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente , Resultado do Tratamento , Caminhada/fisiologiaRESUMO
The objective of the present study was to examine the attentional demands of gait adaptations required to walk over irregular terrain in community-dwelling people with chronic stroke. Eight community ambulators (>6 months post-stroke, aged 57 ± 15 years) and eight age-matched healthy controls participated in the study. As the primary motor task, participants walked on a treadmill while they quickly reacted to a sudden obstacle in front of the affected (in the stroke group) or left (in healthy controls) leg. The secondary, cognitive task was an auditory Stroop task. Outcomes were avoidance success rate and muscle reaction times of the biceps and rectus femoris (motor task), and a composite score of accuracy and verbal reaction time (cognitive task). Success rates did not differ between single- and dual-task conditions in either group, while muscle reaction times deteriorated equally during the dual task in both groups. However, compared with the Stroop scores just before and after obstacle crossing, the scores while crossing the obstacle deteriorated more in the stroke group than in the controls (p=0.012). The higher dual-task costs on the Stroop task reflect greater attentional demands during walking and crossing obstacles. The absence of dual-task effects on obstacle avoidance performance suggests that the people with stroke used a "posture-first strategy". The results imply that common daily life tasks such as obstacle crossing while walking require disproportionate attention even in well-recovered people with stroke.
Assuntos
Atenção/fisiologia , Transtornos Neurológicos da Marcha/fisiopatologia , Desempenho Psicomotor/fisiologia , Acidente Vascular Cerebral/complicações , Caminhada/fisiologia , Estimulação Acústica , Adulto , Idoso , Estudos de Casos e Controles , Doença Crônica , Teste de Esforço/métodos , Feminino , Transtornos Neurológicos da Marcha/etiologia , Humanos , Vida Independente , Masculino , Pessoa de Meia-Idade , Destreza Motora/fisiologia , Estimulação Luminosa , Equilíbrio Postural/fisiologia , Tempo de Reação , Valores de Referência , Características de Residência , Índice de Gravidade de Doença , Acidente Vascular Cerebral/diagnóstico , Reabilitação do Acidente Vascular Cerebral , Análise e Desempenho de TarefasRESUMO
BACKGROUND: Walking ability of people with foot drop in the chronic phase after stroke is better with functional electrical stimulation (FES) of the peroneal nerve than without an orthotic device. However, the literature is not conclusive on whether peroneal FES also is better than an ankle-foot orthosis (AFO) in this regard. OBJECTIVE: This study aimed to identify potential benefits of peroneal FES over an AFO with respect to the ability to negotiate a sudden obstacle. DESIGN: The study design was a within-subject comparison between FES and AFO using repeated measures. METHODS: Twenty-four community-dwelling people with stroke (mean age=52.6 years, SD=12.7) who regularly used a polypropylene AFO were fitted with a transcutaneous FES device. The participants' obstacle avoidance ability was tested after 2 and 8 weeks. They had to avoid 30 obstacles that were suddenly dropped on a treadmill in front of the affected leg while walking with either FES or an AFO. The obstacle avoidance success rates were determined. RESULTS: Success rates were higher with FES than with an AFO, especially after adjustment for individual leg muscle strength. Participants with relatively low muscle strength (Motricity Index score <64) were most likely to benefit from FES regarding obstacle avoidance ability. LIMITATION: Further work is needed to determine whether the results may be generalized to other groups of people with stroke. CONCLUSIONS: Peroneal FES seems to be superior to an AFO with regard to obstacle avoidance ability in community-dwelling people with stroke. The observed gains in obstacle avoidance ability appear to be clinically most relevant in the people with relatively low leg muscle strength.
Assuntos
Terapia por Estimulação Elétrica/métodos , Transtornos Neurológicos da Marcha/reabilitação , Aparelhos Ortopédicos , Nervo Fibular , Reabilitação do Acidente Vascular Cerebral , Análise de Variância , Tornozelo/inervação , Tornozelo/fisiopatologia , Feminino , Pé/inervação , Pé/fisiopatologia , Transtornos Neurológicos da Marcha/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Limitação da Mobilidade , Polipropilenos , Acidente Vascular Cerebral/fisiopatologiaRESUMO
In recent years, the use of functional electrical stimulation (FES) of the peroneal nerve has increased as an alternative for an ankle-foot orthosis (AFO) to treat stroke-related drop foot. We present a chronic stroke patient demonstrating an almost normal gait pattern with peroneal FES as a neuroprosthesis. A 60-year-old survivor of a right hemisphere infarction 21 months ago, who regularly used a polypropylene AFO, was provided with a surface-based peroneal FES device for severe drop foot. In a second instance, he received an implanted FES system because of skin problems with the surface stimulator. With both FES devices, the patient achieved an adequate foot elevation. Moreover, his hip and knee flexion angles during walking increased to normal values and his ankle push-off power increased. His gait pattern became almost symmetrical and less variable than with the AFO. Furthermore, his ability to avoid a sudden obstacle improved to normal values with FES. Our patient showed benefits from peroneal FES beyond what can be attributed to improved foot lift alone. With regard to the potential working mechanisms underlying this response to FES, biomechanical benefits related to improved ankle push-off are suggested as the main mechanism.
Assuntos
Terapia por Estimulação Elétrica/métodos , Transtornos Neurológicos da Marcha/reabilitação , Reabilitação do Acidente Vascular Cerebral , Doença Crônica , Transtornos Neurológicos da Marcha/etiologia , Transtornos Neurológicos da Marcha/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Nervo Fibular , Acidente Vascular Cerebral/complicações , Acidente Vascular Cerebral/fisiopatologiaRESUMO
OBJECTIVE: The aim of this study was to evaluate whether community-dwelling chronic stroke patients wearing an ankle-foot orthosis would benefit from changing to functional electrical stimulation of the peroneal nerve. METHODS: In 26 community-dwelling chronic (> 6 months post-onset) patients after stroke, their ankle-foot orthosis was replaced by a surface-based functional electrical stimulation device (NESS L300). Comfortable walking speed over 10 m was measured at baseline with the ankle-foot orthosis and after 2 and 8 weeks with both ankle-foot orthosis and functional electrical stimulation. The level of physical activity was assessed with a pedometer, and patients' satisfaction was assessed with a questionnaire at baseline and at week 8 regarding ankle-foot orthosis and functional electrical stimulation, respectively. RESULTS: Ankle-foot orthosis and functional electrical stimulation were equally effective with regard to walking speed and activity level. The participants were more satisfied with functional electrical stimulation than with their ankle-foot orthosis regarding the effort and stability of walking, quality of the gait pattern, walking distance, comfort of wearing and appearance of the device. CONCLUSION: The patients judged functional electrical stimulation superior to their ankle-foot orthosis, but measurements of walking speed and physical activity could not objectify the experienced benefits of functional electrical stimulation. Other outcome measures focusing on the stability and effort of ambulation may objectify the perceived benefits of functional electrical stimulation in community-dwelling chronic stroke patients.